My Experience With Antipsychotic Weight Gain
A realistic account of medication-related weight gain, plus practical options worth discussing with a knowledgeable clinician.

In this article
This article combines one person's experience with general educational information. Individual responses to antipsychotics vary widely. Do not stop, switch, or change the dose of an antipsychotic on your own; abrupt changes can cause withdrawal symptoms or a return of the condition being treated. A prescriber can help weigh mental-health benefits, metabolic effects, and treatment options.
The honest starting point
Losing weight—or even maintaining weight—while taking an antipsychotic medication can be extremely difficult. At times, it may feel borderline impossible. Weight gain is a major reason some people consider stopping treatment. That can be especially devastating for someone taking an antipsychotic to augment treatment for depression: you already feel depressed and anxious, and then a change in appetite or weight gets thrown into the mix.
The frustration is real. So is the need to protect the mental-health stability the medication may be providing. Both deserve to be taken seriously.
Quetiapine weight gain
I have experienced extraordinary weight gain on two medications. The first was Seroquel (quetiapine). I took it for only a couple of weeks, and during that time I gained nearly 20 pounds. I was constantly hungry, especially for high-carbohydrate foods. I was all about the three C's: cookies, cakes, and candies. It did not help that I was emotionally distraught at the time. I had no willpower left to fight it.
Abilify weight gain
My second experience was with Abilify (aripiprazole), and it was more recent. I had a hard time one summer and asked my prescriber whether I could add something to my medication regimen to help. I started a very small dose. The weight gain was difficult to detect at first.
While taking the medication, I followed a way of eating that had helped me maintain my weight in the past. After seven months on the medication and a 35-pound gain, I stopped taking Abilify.
Personal response can differ from the average
Aripiprazole is usually considered lower-risk for weight gain than several other antipsychotics, but lower average risk does not mean zero risk. My experience is a reminder that individual monitoring matters.
Weight-gain potential across antipsychotics
The categories below are broad, relative groupings rather than predictions. Dose, treatment duration, age, prior exposure, sleep, activity, other medications, and individual biology can all influence what happens.¹
- Higher: clozapine; olanzapine
- Moderate: chlorpromazine; quetiapine; risperidone; paliperidone
- Lower on average: aripiprazole; amisulpride; asenapine; haloperidol; ziprasidone; lurasidone
| Relative tendency | Medications |
|---|---|
| Higher | Clozapine; olanzapine |
| Moderate | Chlorpromazine; quetiapine; risperidone; paliperidone |
| Lower on average | Aripiprazole; amisulpride; asenapine; haloperidol; ziprasidone; lurasidone |
How can you maintain or lose weight while taking an antipsychotic?
There is no single fix, and struggling with weight is not a character flaw. The most useful plan usually combines early monitoring, realistic nutrition and movement support, and—when needed—a medication strategy developed with a prescriber.
A lower-carbohydrate pattern
Some people find that reducing refined carbohydrates helps with hunger, blood-sugar swings, and weight management. A lower-carbohydrate pattern can be one option, but it is not the only effective approach and it does not need to mean eliminating all carbohydrates.
Atkins-style or ketogenic diets can work for some people in the general population, but the best evidence does not support one diet for everyone. Food quality, adequate protein and fiber, sustainability, and total energy intake still matter. Very-low-carbohydrate diets may not fit pregnancy, eating-disorder recovery, diabetes treatment, kidney or liver disease, or some medication plans without professional guidance.
- Notice whether the medication has changed hunger, cravings, meal timing, or nighttime eating.
- Prioritize protein, fiber-rich foods, minimally processed carbohydrates, and regular meals that are actually satisfying.
- Ask for early tracking of weight, waist circumference, blood pressure, glucose or A1C, and lipids when appropriate.
- Choose movement that is repeatable and compatible with energy level, sedation, pain, and current mental health.
Leveling the playing field
Antipsychotics can change appetite, satiety, activity, sleep, and metabolic risk. That is a difficult combination to fight through willpower alone. Lifestyle support matters, but needing additional help is not failure.
Psychiatrists and primary-care clinicians can discuss monitoring, the dose, a lower-risk alternative when clinically appropriate, or an add-on treatment. WHO guidance supports lifestyle intervention for people at risk and says switching to a lower-propensity medication or considering metformin may be appropriate in selected cases under clinical supervision.²
Herbs and fiber supplements
Some supplements have plausible mechanisms or early signals, but evidence specifically for antipsychotic-associated weight gain is limited. Product quality, interactions, pregnancy, and existing medical conditions matter. Review any supplement with a pharmacist or clinician who knows your full medication list.
1. Berberine
Berberine is a compound found in several plants. A 2022 randomized trial in people with schizophrenia reported that adjunctive berberine attenuated antipsychotic-associated weight and metabolic changes. That is encouraging, but it is one study and does not establish that berberine is appropriate for every person taking an antipsychotic.³ Berberine can cause gastrointestinal effects and interact with medicines; it should not be used during pregnancy or breastfeeding.⁴
2. Chitosan
Chitosan is derived from chitin and is marketed as a fat-binding supplement. Reviews have found, at most, a small effect on weight, and analyses restricted to higher-quality trials have found effects that may not be clinically meaningful.⁵ Evidence is not specific to antipsychotic-associated weight gain.
3. PGX
PGX is a viscous fiber blend. When taken with enough water, viscous fiber can increase fullness and may support modest weight management. Evidence specific to antipsychotic-associated weight gain is lacking. Fiber products can affect digestion and the timing or absorption of some medications, so spacing and fluid intake should be reviewed with a pharmacist.
4. Fenugreek
A short-term study in otherwise healthy adults with overweight found that a fenugreek seed extract slightly reduced spontaneous fat intake, but it did not study people with antipsychotic-associated weight gain.⁶ Fenugreek can cause digestive symptoms, allergic reactions, and low blood sugar; supplement-level doses are not considered safe during pregnancy, and interactions are possible.⁷
The product links in the original article were supplied for reference. A product link is not a guarantee of quality, safety, purity, or benefit. Dietary supplements are not evaluated like prescription medicines before sale, and products marketed for weight loss may vary substantially.
OTC medication: Alli (orlistat)
Orlistat is an FDA-approved over-the-counter weight-management medication for adults who meet the label criteria. It inhibits gastrointestinal lipases, reducing absorption of some dietary fat.
The Alli label says that, for every five pounds lost through diet, orlistat may help a person lose another two to three pounds. It should be paired with a balanced, reduced-calorie, low-fat diet. Common effects include oily spotting, gas with discharge, loose stools, and urgency. Because it can reduce absorption of fat-soluble vitamins, the label advises a daily multivitamin at bedtime. Restrictions and cautions include cyclosporine, warfarin, diabetes or thyroid medicines, pregnancy, and certain digestive, gallbladder, or pancreatic conditions.⁸
Antipsychotic-associated weight gain involves more than dietary fat absorption, so orlistat is one possible tool rather than a direct reversal of the medication's metabolic effects. A pharmacist can check whether it fits the rest of a medication regimen.
Prescription medications
Prescription options can be useful when weight or metabolic changes continue despite practical lifestyle support. These are individualized decisions that require assessment, monitoring, and a clear discussion of benefits and side effects.
Metformin is a diabetes medication that reduces liver glucose production and improves insulin sensitivity. It is the most extensively studied medication for preventing and treating antipsychotic-associated weight gain. A recent evidence-based guideline found that starting metformin alongside an antipsychotic reduced the extent of weight gain by about 4 kg on average compared with controls in the studies reviewed.⁹
That does not make metformin an automatic choice. Kidney function, gastrointestinal tolerance, vitamin B12 over longer-term use, other health conditions, and the timing of treatment all matter. Metformin does not block calories from sugar in the intestine.
Topiramate is an antiseizure medication that is also used for migraine prevention. Randomized-trial meta-analyses suggest it can reduce weight or mitigate weight gain in some people taking antipsychotics.¹⁰ Possible adverse effects include tingling sensations, cognitive slowing or word-finding difficulty, taste changes, kidney stones, metabolic acidosis, and pregnancy-related fetal risk. It must be prescribed and monitored with those tradeoffs in mind.
A more workable conclusion
There are real options for leveling the playing field when antipsychotic treatment changes appetite, weight, or metabolic health. Lifestyle changes can help, but they are not always enough on their own. Supplements have limited and uneven evidence. Orlistat may be appropriate for some adults. Metformin has the strongest evidence base in this specific setting, and topiramate has supportive evidence but a different side-effect profile.
Many people need an antipsychotic, whether it is being used for depression, severe anxiety, bipolar disorder, schizophrenia, or another condition. The goal is not to shame anyone into choosing between mental stability and physical health. The goal is collaborative care: notice changes early, ask for metabolic monitoring, and work with a knowledgeable clinician on a plan that respects both.
A useful conversation starter
You might ask: What changes should we monitor? How quickly? Does this medication have a lower-risk alternative that would still meet my mental-health needs? At what point would metformin or another evidence-supported option make sense? What should I know before adding an OTC medicine or supplement?
References
¹ Pillinger T, et al. Comparative effects of 18 antipsychotics on metabolic function. Lancet Psychiatry. 2020. https://pubmed.ncbi.nlm.nih.gov/31806468/
² World Health Organization. Management of physical health conditions in adults with severe mental disorders. 2018. https://www.who.int/publications/i/item/9789241550383
³ Chan M, et al. Adjunctive berberine reduces antipsychotic-associated weight gain and metabolic syndrome in patients with schizophrenia: a randomized controlled trial. Psychiatry Clin Neurosci. 2022;76(3):77-85. https://doi.org/10.1111/pcn.13323
⁴ National Center for Complementary and Integrative Health. Berberine and Weight Loss: What You Need To Know. https://www.nccih.nih.gov/health/berberine-and-weight-loss-what-you-need-to-know
⁵ Ni Mhurchu C, et al. Effect of chitosan on weight loss in overweight and obese individuals: a systematic review of randomized controlled trials. Obes Rev. 2005;6(1):35-42. https://pubmed.ncbi.nlm.nih.gov/15644040/
⁶ Chevassus H, et al. A fenugreek seed extract selectively reduces spontaneous fat intake in overweight subjects. Eur J Clin Pharmacol. 2010;66(5):449-455. https://pubmed.ncbi.nlm.nih.gov/20020282/
⁷ National Center for Complementary and Integrative Health. Fenugreek: Usefulness and Safety. https://www.nccih.nih.gov/health/fenugreek
⁸ U.S. Food and Drug Administration. Alli (orlistat) Drug Facts label. https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021887s013lbl.pdf
⁹ Carolan A, et al. Metformin for the prevention of antipsychotic-induced weight gain: guideline development and consensus validation. Schizophr Bull. 2025;51(5):1193-1205. https://pubmed.ncbi.nlm.nih.gov/40319000/
¹⁰ Goh KK, et al. Topiramate mitigates weight gain in antipsychotic-treated patients with schizophrenia: meta-analysis of randomised controlled trials. Int J Psychiatry Clin Pract. 2019;23(1):14-32. https://pubmed.ncbi.nlm.nih.gov/30244521/
Words worth knowing
Cognitive behavioral therapy (CBT)
A structured therapy that helps people notice patterns between thoughts, feelings, and actions, then practice more helpful responses.
